During the past decade, Klinikum Memmingen conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Memmingen" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "AGO Research GmbH" with 1 trials sponsored, "Aesculap AG" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Coloplast A/S" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Memmingen" #1 collaborator was "Aesculap, Inc." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Memmingen" are "Atrial Fibrillation" (2 trials), "Breast Cancer" (2 trials), "Appendicitis" (1 trials), "Brady Tachy Syndrome" (1 trials) and "Bradycardia" (1 trials). Many other conditions were trialed in "Klinikum Memmingen" in a lesser frequency.

Most popular intervention types in "Klinikum Memmingen" are "Device" (7 trials), "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACE inhibitor, angiotensin receptor blocker" (1 trials), "Altis Single Incision Sling" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Memmingen" are 9 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Memmingen". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Klinikum Memmingen, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Memmingen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".